Tumor-Induced Immune Suppression : Mechanisms and Therapeutic Reversal /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2014.
|
| Edición: | 2nd ed. 2014. |
| Materias: |
Tabla de Contenidos:
- Preface.- Regulatory T Cells and Cancer
- Th17 cells in cancer
- Mast cells and immune response in cancer
- Myeloid-Derived Suppressor Cells in Tumor-Induced T-Cell Suppression and Tolerance
- Immunobiology of Dendritic Cells in Cancer
- Macrophages and Tumor Development
- Angiogenesis and Immune Suppression in Cancer
- Tim-3 Regulation of Cancer Immunity.- Transcriptional Regulation of Dendritic Cells in The Tumor Microenvironment
- S100A9, Inflammation, and Regulation of Immune Suppression in Cancer
- IDO in Inflammatory Programming and Immune Suppression in Cancer
- Defining the Fate and Function of Effector T cells through Galectin-1 - Galectin-1 Ligand Binding Interactions: Implications in Tumor Immunity
- Arginine Metabolism, a Major Pathway for the Suppressive Function of Myeloid-derived Suppressor Cells.- The Hypoxia-Adenosinergic Immunosuppression and Redirection of Immune Response in Tumor Microenvironment
- Molecular Pathways in Antigen Presenting Cells Involved in the Induction of Antigen-Specific T-Cell Tolerance
- Overcoming Immune Suppression: Therapeutic Strategies Targeting T-Cell Function in Cancer
- Index.